• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

口腔鳞状细胞癌中癌干细胞起源的多样性及其临床意义

Diversity of the Origin of Cancer Stem Cells in Oral Squamous Cell Carcinoma and Its Clinical Implications.

作者信息

Fukumoto Chonji, Uchida Daisuke, Kawamata Hitoshi

机构信息

Department of Oral and Maxillofacial Surgery, Dokkyo Medical University School of Medicine, 880 Kitakobayashi, Shimo-Tsuga, Mibu 321-0293, Tochigi, Japan.

Department of Oral and Maxillofacial Surgery, Ehime University Graduate School of Medicine, 454 Shitsukawa, Toon 791-0295, Ehime, Japan.

出版信息

Cancers (Basel). 2022 Jul 22;14(15):3588. doi: 10.3390/cancers14153588.

DOI:10.3390/cancers14153588
PMID:35892847
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9332248/
Abstract

Oral squamous cell carcinoma (OSCC) histopathologically accounts for ≥90% of oral cancer. Many clinicopathological risk factors for OSCC have also been proposed, and postoperative therapy is recommended in guidelines based on cancer stage and other risk factors. However, even if the standard treatment is provided according to the guidelines, a few cases rapidly recur or show cervical and distant metastasis. In this review article, we focus on the diversity of the origin of OSCC. We also discuss cancer stem cells (CSCs) as a key player to explain the malignancy of OSCC. CSCs are a subset of cancer cells that occupy a very small portion of the cancer mass and have characteristics of stem cells. When gene abnormalities accumulate in somatic stem cells, those cells transform into CSCs. CSCs as the origin of cancer then autonomously grow and develop into cancer. The histopathological phenotype of cancer cells is determined by the original characteristics of the somatic stem cells and/or surrounding environment. OSCC may be divided into the following three categories with different malignancy based on the origin of CSCs: cancer from oral epithelial stem cell-derived CSCs, cancer from stem cells in salivary gland-derived CSCs, and cancer from bone marrow-derived stem cell-derived CSCs.

摘要

口腔鳞状细胞癌(OSCC)在组织病理学上占口腔癌的≥90%。人们还提出了许多OSCC的临床病理危险因素,并且指南根据癌症分期和其他危险因素推荐术后治疗。然而,即使按照指南提供标准治疗,仍有少数病例会迅速复发或出现颈部和远处转移。在这篇综述文章中,我们关注OSCC起源的多样性。我们还讨论了癌症干细胞(CSCs)作为解释OSCC恶性程度的关键因素。CSCs是癌细胞的一个亚群,在癌组织中所占比例非常小,并具有干细胞的特征。当基因异常在体干细胞中积累时,这些细胞会转化为CSCs。作为癌症起源的CSCs随后自主生长并发展成癌症。癌细胞的组织病理表型由体干细胞的原始特征和/或周围环境决定。根据CSCs的起源,OSCC可分为以下三类,其恶性程度不同:源自口腔上皮干细胞的CSCs的癌症、源自唾液腺干细胞的CSCs的癌症以及源自骨髓干细胞的CSCs的癌症。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/785a/9332248/50ae85003194/cancers-14-03588-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/785a/9332248/6f51af42340e/cancers-14-03588-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/785a/9332248/6cb3a163bdd6/cancers-14-03588-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/785a/9332248/7799597b9e2d/cancers-14-03588-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/785a/9332248/50ae85003194/cancers-14-03588-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/785a/9332248/6f51af42340e/cancers-14-03588-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/785a/9332248/6cb3a163bdd6/cancers-14-03588-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/785a/9332248/7799597b9e2d/cancers-14-03588-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/785a/9332248/50ae85003194/cancers-14-03588-g004.jpg

相似文献

1
Diversity of the Origin of Cancer Stem Cells in Oral Squamous Cell Carcinoma and Its Clinical Implications.口腔鳞状细胞癌中癌干细胞起源的多样性及其临床意义
Cancers (Basel). 2022 Jul 22;14(15):3588. doi: 10.3390/cancers14153588.
2
Oral squamous cell carcinoma may originate from bone marrow-derived stem cells.口腔鳞状细胞癌可能起源于骨髓来源的干细胞。
Oncol Lett. 2021 Feb;21(2):170. doi: 10.3892/ol.2021.12431. Epub 2021 Jan 4.
3
Suppression of miR-204 enables oral squamous cell carcinomas to promote cancer stemness, EMT traits, and lymph node metastasis.miR-204的抑制使口腔鳞状细胞癌能够促进癌症干性、上皮-间质转化特征和淋巴结转移。
Oncotarget. 2016 Apr 12;7(15):20180-92. doi: 10.18632/oncotarget.7745.
4
MicroRNA-495 confers inhibitory effects on cancer stem cells in oral squamous cell carcinoma through the HOXC6-mediated TGF-β signaling pathway.miRNA-495 通过 HOXC6 介导的 TGF-β 信号通路对口腔鳞状细胞癌细胞中的肿瘤干细胞发挥抑制作用。
Stem Cell Res Ther. 2020 Mar 14;11(1):117. doi: 10.1186/s13287-020-1576-3.
5
The Hippo transducer TAZ promotes epithelial to mesenchymal transition and cancer stem cell maintenance in oral cancer.河马信号转导蛋白TAZ促进口腔癌中的上皮-间质转化和癌症干细胞维持。
Mol Oncol. 2015 Jun;9(6):1091-105. doi: 10.1016/j.molonc.2015.01.007. Epub 2015 Feb 9.
6
Relevance of cancer initiating/stem cells in carcinogenesis and therapy resistance in oral cancer.口腔癌发生和治疗耐药中癌症起始/干细胞的相关性。
Oral Oncol. 2013 Sep;49(9):854-862. doi: 10.1016/j.oraloncology.2013.06.010. Epub 2013 Jul 19.
7
Methods for Overcoming Chemoresistance in Head and Neck Squamous Cell Carcinoma: Keeping the Focus on Cancer Stem Cells, a Systematic Review.克服头颈部鳞状细胞癌化疗耐药性的方法:聚焦癌症干细胞,一项系统综述
Cancers (Basel). 2024 Aug 29;16(17):3004. doi: 10.3390/cancers16173004.
8
Targeting CD133 in the enhancement of chemosensitivity in oral squamous cell carcinoma-derived side population cancer stem cells.靶向CD133增强口腔鳞状细胞癌来源的侧群癌干细胞的化疗敏感性
Head Neck. 2016 Apr;38 Suppl 1:E231-8. doi: 10.1002/hed.23975. Epub 2015 Jun 4.
9
Sulforaphane targets cancer stemness and tumor initiating properties in oral squamous cell carcinomas via miR-200c induction.萝卜硫素通过诱导miR-200c靶向口腔鳞状细胞癌中的癌症干性和肿瘤起始特性。
J Formos Med Assoc. 2017 Jan;116(1):41-48. doi: 10.1016/j.jfma.2016.01.004. Epub 2016 Feb 12.
10
Lactate Promotes Cancer Stem-like Property of Oral Sequamous Cell Carcinoma.乳酸促进口腔鳞状细胞癌的癌症干细胞样特性。
Curr Med Sci. 2019 Jun;39(3):403-409. doi: 10.1007/s11596-019-2050-2. Epub 2019 Jun 17.

引用本文的文献

1
Epigenetic Treatment Alters Immune-Related Gene Signatures to Increase the Sensitivity of Anti PD-L1 Drugs.表观遗传治疗改变免疫相关基因特征以提高抗PD-L1药物的敏感性。
Cancers (Basel). 2025 Jul 23;17(15):2431. doi: 10.3390/cancers17152431.
2
Prediction of pathological grade of oral squamous cell carcinoma and construction of prognostic model based on deep learning algorithm.基于深度学习算法的口腔鳞状细胞癌病理分级预测及预后模型构建
Discov Oncol. 2025 Jun 1;16(1):976. doi: 10.1007/s12672-025-02144-8.
3
Tribbles pseudokinase 3 drives cancer stemness in oral squamous cell carcinoma cells by supporting the expression levels of SOX2 and EGFR.

本文引用的文献

1
Searching for New Molecular Targets for Oral Squamous Cell Carcinoma with a View to Clinical Implementation of Precision Medicine.寻找口腔鳞状细胞癌的新分子靶点以期实现精准医学的临床应用。
J Pers Med. 2022 Mar 7;12(3):413. doi: 10.3390/jpm12030413.
2
Literature review of cancer stem cells in oral lichen planus: a premalignant lesion.口腔扁平苔藓中癌干细胞的文献综述:一种癌前病变
Stem Cell Investig. 2021 Dec 30;8:25. doi: 10.21037/sci-2020-049. eCollection 2021.
3
Oral Cancer Stem Cells: Therapeutic Implications and Challenges.
TRIBbles假激酶3通过维持SOX2和表皮生长因子受体(EGFR)的表达水平,驱动口腔鳞状细胞癌细胞的肿瘤干性。
Int J Mol Med. 2025 Mar;55(3). doi: 10.3892/ijmm.2025.5485. Epub 2025 Jan 10.
4
Identification and Validation of a Prognostic Signature Derived from the Cancer Stem Cells for Oral Squamous Cell Carcinoma.基于口腔鳞状细胞癌肿瘤干细胞的预后标志物的鉴定与验证。
Int J Mol Sci. 2024 Jan 14;25(2):1031. doi: 10.3390/ijms25021031.
5
Biological biomarkers of oral cancer.口腔癌的生物学标志物。
Periodontol 2000. 2024 Oct;96(1):250-280. doi: 10.1111/prd.12542. Epub 2023 Dec 10.
6
Expression of the Embryonic Cancer Stem Cells' Biomarkers SOX2 and OCT3/4 in Oral Leukoplakias and Squamous Cell Carcinomas: A Preliminary Study.胚胎癌干细胞生物标志物SOX2和OCT3/4在口腔白斑和鳞状细胞癌中的表达:一项初步研究。
Cureus. 2023 Sep 18;15(9):e45482. doi: 10.7759/cureus.45482. eCollection 2023 Sep.
7
The Role of Hedgehog Signaling Pathway in Head and Neck Squamous Cell Carcinoma.Hedgehog 信号通路在头颈部鳞状细胞癌中的作用。
Cells. 2023 Aug 17;12(16):2083. doi: 10.3390/cells12162083.
8
Mechanisms involved in cancer stem cell resistance in head and neck squamous cell carcinoma.头颈部鳞状细胞癌中癌症干细胞耐药的相关机制。
Cancer Drug Resist. 2023 Feb 21;6(1):116-137. doi: 10.20517/cdr.2022.107. eCollection 2023.
口腔癌干细胞:治疗意义与挑战
Front Oral Health. 2021 Jul 21;2:685236. doi: 10.3389/froh.2021.685236. eCollection 2021.
4
Clinicopathological Characteristics and Survival Outcomes of Patients with Buccal Squamous Cell Carcinoma: Results of a Multi-Institutional Study.颊黏膜鳞状细胞癌患者的临床病理特征和生存结局:一项多机构研究的结果。
Medicina (Kaunas). 2021 Dec 13;57(12):1361. doi: 10.3390/medicina57121361.
5
Surveillance for Patients with Oral Squamous Cell Carcinoma after Complete Surgical Resection as Primary Treatment: A Single-Center Retrospective Cohort Study.口腔鳞状细胞癌患者接受完全手术切除作为主要治疗后的监测:一项单中心回顾性队列研究
Cancers (Basel). 2021 Nov 21;13(22):5843. doi: 10.3390/cancers13225843.
6
Role of cancer stem cells in head-and-neck squamous cell carcinoma - A systematic review.癌症干细胞在头颈部鳞状细胞癌中的作用——一项系统综述
J Carcinog. 2021 Sep 23;20:12. doi: 10.4103/jcar.JCar_14_20. eCollection 2021.
7
A systematic review of proteomic biomarkers in oral squamous cell cancer.口腔鳞状细胞癌中蛋白质组学标志物的系统评价。
World J Surg Oncol. 2021 Oct 28;19(1):315. doi: 10.1186/s12957-021-02423-y.
8
The Balance between Differentiation and Terminal Differentiation Maintains Oral Epithelial Homeostasis.分化与终末分化之间的平衡维持口腔上皮稳态。
Cancers (Basel). 2021 Oct 13;13(20):5123. doi: 10.3390/cancers13205123.
9
Cancer stem cells in head and neck cancer.头颈癌中的癌症干细胞。
Am J Stem Cells. 2021 Aug 15;10(3):28-35. eCollection 2021.
10
Salivary Cytokines as Biomarkers for Oral Squamous Cell Carcinoma: A Systematic Review.唾液细胞因子作为口腔鳞状细胞癌生物标志物的系统评价。
Int J Mol Sci. 2021 Jun 24;22(13):6795. doi: 10.3390/ijms22136795.